Evidence suggests that cGAMP treatment could activate the STING-IRF3 pathway to upregulate TREM2 expression, alleviating cognitive deficits and pathological changes in APP/PS1 transgenetic mice [179]. Here, STING1 is linked to Cognitive impairment.